Idera Pharmaceuticals Email Format
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Idera Pharmaceuticals merged with Aceragen, Inc., a rare disease biopharmaceutical company, in September 2022. The company name was changed to Aceragen in early 2023.